Health Sciences Acquisitions 2 Profit Margin

The latest profit margin for HSAQ is -186.3% as of June 2026. That compares with -2817.24% in the prior-year period — up 93.4% year over year. That is below the sector sector average of 21.34%. Investors often review this figure alongside Health Sciences Acquisitions 2's historical trend and sector peers before judging valuation or financial health.

Over the past year, HSAQ's profit margin moved from -2817.24% to -186.3% — a 93.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Health Sciences Acquisitions 2's valuation or profitability profile.

Against its sector companies, HSAQ currently prints -186.3% for profit margin, while the sector average sits near 21.34%. That is roughly 972.9% below the sector mean. Large gaps often invite a closer look at Health Sciences Acquisitions 2's growth, margins, and balance sheet.

Profit Margin shows how effectively Health Sciences Acquisitions 2 converts resources into returns. At -186.3%, HSAQ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2817.24% in the prior-year period — up 93.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HSAQ's profit margin (-186.3%), review year-over-year change from -2817.24%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.